Globe Newswire
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser:OCTOPUS INVESTMENTS LTD(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient.... (continue reading...)LOS ANGELES, May 31, 2024 (GLOBE NEWSWIRE) -- via IBN -- Torr Metals Inc. (TSX.V: TMET), a Canada-based company focused on advancing promising early-stage district-scale mineral properties, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers... (continue reading...)
- Established Medium Dose as Safe and Tolerable Dose in Current OCU410 Clinical Trial
- DSMB Recommends Continuing with High-Dose Cohort Dosing with Concurrent Phase 2 Dosing
MALVERN, Pa., May 31, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced a positive outcome of the Data and Safety Monitoring Board... (continue reading...)
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser:OCTOPUS INVESTMENTS LTD(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient.... (continue reading...)The Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
CALGARY, Alberta, May 31, 2024 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ: SNDL), Canada’s largest private-sector regulated products platform, today announced that Zach George, Chief Executive Officer, will present live at KCSA Cannabis Virtual Investor Conference hosted by VirtualInvestorConferences.com and co-sponsored by KCSA... (continue reading...)
More Globe Newswire
View Older Stories-
Glass House Brands to Present at the KCSA Cannabis Virtual Investor Conference June 5th
-
Interim Report for the period January 1 – March 31, 2024
-
The Real Good Food Company Receives Nasdaq Notice Regarding Filing Requirements
-
Global Water Resources Declares Monthly Dividend
-
EMCORE's Chief Scientist Sergey Zotov to Present a Talk on the Journey from Tactical to High-End Navigation-Grade MEMS Accelerometers at the Joint Navigation Conference
-
Victory Square Technologies Reports Q1 2024 Financial Results
-
Sharps Technology’s SC Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.
-
Mullen Announces Hiring of Former European Manheim and Copart Executive, Alain Van Munster, to Lead Europe Sales Efforts
-
AIM ImmunoTech Announces Pricing of $2.0 Million Registered Direct Offering
-
La Rosa to Present at the Spring MicroCap Rodeo Conference on June 6th
-
SRIVARU (SVMH) to Present at the Spring MicroCap Rodeo Conference on June 6th
-
Inuvo CEO to Participate in Fireside Chat at the Maxim Group TMT Conference on June 5, 2024
-
Jet.AI to Present at the Maxim Group Virtual TMT Conference on Tuesday, June 4, 2024
-
HealthPRO Canada Delivers Tangible Sustainability Strategies to Empower Healthcare Organizations
-
Vow ASA: Breakthrough contract confirmed in cruise
-
Form 8.3 - Lok’n Store Group PLC
-
Form 8.3 - Balanced Commercial Property Trust Limited
-
Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update
-
Twin Disc, Inc. Completes Acquisition of Katsa Oy
-
Haoxi Health Technology Limited Reports Unaudited Financial Results for The Six Months Ended December 31, 2023
-
Generation Lab Introduces First Platform that Measures Aging & Treatment Efficacy to Help Extend the Human Healthspan
-
Rogers starts to expand 5G network to rest of TTC subway system
-
Solar Alliance reports profitable Q1 result supported by 70% year-over-year revenue increase
-
PrairieSky Receives TSX Approval for Renewed Normal Course Issuer Bid
-
Total Energy Services Inc. Announces Dividend
-
SS Innovations Engages BDO as its new Auditor
-
Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Bionomics Limited Announces Private Placement of up to $70.0 Million
-
eGain Announces Increase to Stock Repurchase Program of $20 Million
-
ABM Named Among Barron’s 100 Most Sustainable Companies for Second Consecutive Year
-
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus
-
Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference
-
Morphic to Participate in Jefferies Global Healthcare Conference
-
Bitdeer Announces Up to $150 Million Private Placement Financing
-
Autolus Therapeutics presents longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL in an oral presentation at ASCO
-
PodcastOne (Nasdaq: PODC) Appoints Wall Street Veteran Jon Merriman to Its Board of Directors
-
Iterum Therapeutics Receives FDA Acceptance of Resubmission of NDA for Oral Sulopenem for the treatment of Uncomplicated Urinary Tract Infections
-
FOREWARN Partners with Santa Barbara Multiple Listing Service
-
Novartis Scemblix® Phase III data first to show superior efficacy with a favorable safety and tolerability profile vs. standard-of-care TKIs in adults with newly diagnosed CML
-
Director/PDMR Shareholding
-
Form 8.3 - [LOK'N STORE GROUP PLC - 30 05 2024] - (CGWL)
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 30 05 2024] - (CGWL)
-
Li Auto Inc. Announces Results of Annual General Meeting
-
Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
-
TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
-
Huhtamaki to consolidate its production footprint in United Arab Emirates
-
Veðskuld slhf. - Aðrar upplýsingar sem birtar eru í samræmi við reglur Kauphallarinnar
-
SciSparc Secures Strategic Advantage with Grant of European Patent
-
SciSparc Secures Strategic Advantage with Grant of European Patent
-
CEO Peter Røpke to resign from RTX at the end of November 2024
